-
Something wrong with this record ?
Agar Composition Modulates Production of Trichoderma Peptaibols, Affecting Antibacterial and Antiproliferative Activity
P. Macášek, A. Kapustová, J. Viktorová, J. Víglaš, P. Olejníková, L. Grey, L. Laubertová, H. Gbelcová
Language English Country United States
Document type Journal Article
Grant support
INTER-COST LUC24099 (COST Action CA21145 EURESTOP)
Ministerstvo Školství, Mládeže a Tělovýchovy
UK/3211/2024
Univerzita Komenského v Bratislave
VEGA 1/0388/22
Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR
APVV-19-0094
Agentúra na Podporu Výskumu a Vývoja
- MeSH
- Agar * chemistry MeSH
- Anti-Bacterial Agents * pharmacology metabolism MeSH
- Hypocreales MeSH
- Culture Media chemistry MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Cell Line, Tumor MeSH
- Peptaibols * pharmacology metabolism biosynthesis chemistry MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents * pharmacology metabolism MeSH
- Pseudomonas aeruginosa drug effects MeSH
- Staphylococcus aureus drug effects MeSH
- Trichoderma * metabolism growth & development chemistry MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Current antibiotics and chemotherapeutics are becoming ineffective because pathogenic bacteria and tumor cells have developed multiple drug resistance. Therefore, it is necessary to find new substances that can be used in treatment, either alone or as sensitizing molecules in combination with existing drugs. Peptaibols are bioactive, membrane-active peptides of non-ribosomal origin, mainly produced by filamentous fungi such as Trichoderma spp. This study focused on producing peptaibol-rich extracts from Trichoderma atroviride O1, cultivated on malt extract agar (MA) under circadian and constant darkness conditions for 13 days. Peptaibol production was detected by MALDI-TOF mass spectrometry after six days of cultivation. The extracts demonstrated antibacterial activity against Staphylococcus aureus strains, particularly the methicillin-resistant variant, but not against the Gram-negative Pseudomonas aeruginosa. Quorum sensing interference revealed that a peptaibol-rich extract suppressed Vibrio campbellii BAA-1119's AI-2 signaling system to a degree comparable with gentamycin. Beyond antibacterial properties, the extracts exhibited notable antiproliferative activity against human ovarian cancer cells and their adriamycin-resistant subline in both 2D and 3D models. Specifically, MA-derived extracts reduced ovarian cancer cell viability by 70% at 50 μg/mL, especially under light/dark regime of cultivation. Compared to previously published results for PDA-based extracts, MA cultivation shifted the biological effects of peptaibol-containing extracts toward anticancer potential. These findings support the idea that modifying fungal cultivation parameters, the bioactivity of secondary metabolite mixtures can be tailored for specific therapeutic applications.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015280
- 003
- CZ-PrNML
- 005
- 20250731090903.0
- 007
- ta
- 008
- 250708s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00284-025-04322-x $2 doi
- 035 __
- $a (PubMed)40540086
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Macášek, Patrik $u Faculty of Medicine, Institute of Medical Biology, Genetics and Clinical Genetics, Comenius University, Sasinkova 4, 811 08, Bratislava, Slovak Republic
- 245 10
- $a Agar Composition Modulates Production of Trichoderma Peptaibols, Affecting Antibacterial and Antiproliferative Activity / $c P. Macášek, A. Kapustová, J. Viktorová, J. Víglaš, P. Olejníková, L. Grey, L. Laubertová, H. Gbelcová
- 520 9_
- $a Current antibiotics and chemotherapeutics are becoming ineffective because pathogenic bacteria and tumor cells have developed multiple drug resistance. Therefore, it is necessary to find new substances that can be used in treatment, either alone or as sensitizing molecules in combination with existing drugs. Peptaibols are bioactive, membrane-active peptides of non-ribosomal origin, mainly produced by filamentous fungi such as Trichoderma spp. This study focused on producing peptaibol-rich extracts from Trichoderma atroviride O1, cultivated on malt extract agar (MA) under circadian and constant darkness conditions for 13 days. Peptaibol production was detected by MALDI-TOF mass spectrometry after six days of cultivation. The extracts demonstrated antibacterial activity against Staphylococcus aureus strains, particularly the methicillin-resistant variant, but not against the Gram-negative Pseudomonas aeruginosa. Quorum sensing interference revealed that a peptaibol-rich extract suppressed Vibrio campbellii BAA-1119's AI-2 signaling system to a degree comparable with gentamycin. Beyond antibacterial properties, the extracts exhibited notable antiproliferative activity against human ovarian cancer cells and their adriamycin-resistant subline in both 2D and 3D models. Specifically, MA-derived extracts reduced ovarian cancer cell viability by 70% at 50 μg/mL, especially under light/dark regime of cultivation. Compared to previously published results for PDA-based extracts, MA cultivation shifted the biological effects of peptaibol-containing extracts toward anticancer potential. These findings support the idea that modifying fungal cultivation parameters, the bioactivity of secondary metabolite mixtures can be tailored for specific therapeutic applications.
- 650 12
- $a antibakteriální látky $x farmakologie $x metabolismus $7 D000900
- 650 12
- $a peptaiboly $x farmakologie $x metabolismus $x biosyntéza $x chemie $7 D054848
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Trichoderma $x metabolismus $x růst a vývoj $x chemie $7 D014242
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 12
- $a agar $x chemie $7 D000362
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 12
- $a protinádorové látky $x farmakologie $x metabolismus $7 D000970
- 650 _2
- $a kultivační média $x chemie $7 D003470
- 650 _2
- $a Staphylococcus aureus $x účinky léků $7 D013211
- 650 _2
- $a Pseudomonas aeruginosa $x účinky léků $7 D011550
- 650 _2
- $a Hypocreales $7 D006999
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kapustová, Adriana $u Faculty of Medicine, Institute of Medical Biology, Genetics and Clinical Genetics, Comenius University, Sasinkova 4, 811 08, Bratislava, Slovak Republic
- 700 1_
- $a Viktorová, Jitka $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28, Prague, Czech Republic
- 700 1_
- $a Víglaš, Ján $u Faculty of Food and Chemical Technology, Institute of Biochemistry and Microbiology, Slovak University of Technology in Bratislava, 812 37, Bratislava, Slovak Republic
- 700 1_
- $a Olejníková, Petra $u Faculty of Food and Chemical Technology, Institute of Biochemistry and Microbiology, Slovak University of Technology in Bratislava, 812 37, Bratislava, Slovak Republic
- 700 1_
- $a Grey, Lukas $u Faculty of Food and Chemical Technology, Institute of Biochemistry and Microbiology, Slovak University of Technology in Bratislava, 812 37, Bratislava, Slovak Republic
- 700 1_
- $a Laubertová, Lucia $u Faculty of Medicine, Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Comenius University, Sasinkova 4, 811 08, Bratislava, Slovak Republic
- 700 1_
- $a Gbelcová, Helena $u Faculty of Medicine, Institute of Medical Biology, Genetics and Clinical Genetics, Comenius University, Sasinkova 4, 811 08, Bratislava, Slovak Republic. helena.gbelcova@fmed.uniba.sk $1 https://orcid.org/000000031644109X $7 xx0257254
- 773 0_
- $w MED00001275 $t Current microbiology $x 1432-0991 $g Roč. 82, č. 8 (2025), s. 342
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40540086 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731090858 $b ABA008
- 999 __
- $a ok $b bmc $g 2366252 $s 1252405
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 82 $c 8 $d 342 $e 20250620 $i 1432-0991 $m Current microbiology $n Curr Microbiol $x MED00001275
- GRA __
- $a INTER-COST LUC24099 (COST Action CA21145 EURESTOP) $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a UK/3211/2024 $p Univerzita Komenského v Bratislave
- GRA __
- $a VEGA 1/0388/22 $p Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR
- GRA __
- $a APVV-19-0094 $p Agentúra na Podporu Výskumu a Vývoja
- LZP __
- $a Pubmed-20250708